ScholarIQanswers from OpenAlex

Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan

PaperCitations, authors & open-access status

Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan have?

ScholarIQcitation count

Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan has 39 citations in the OpenAlex counts ScholarIQ stores.

When was Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan published?

ScholarIQyear

Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan has 2017 year in the ScholarIQ index.

What is the open-access status of Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan?

ScholarIQoa status

Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan has gold oa status in the ScholarIQ index.

What is the DOI of Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan?

ScholarIQdoi

The DOI for Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan is on the source record.

What is the PMID of Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan?

ScholarIQpmid

The PMID for Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan is on the source record.

What is the OpenAlex record for Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan?

ScholarIQopenalex

The OpenAlex for Safety and effectiveness of tocilizumab in treating patients with rheumatoid arthritis – A three-year study in Taiwan is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial